Papers/PMID:23691095
Meta-analysis: melatonin for the treatment of primary sleep disorders.
PloS one2013The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
melatonin — decreases sleep onset latency
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×10“Our meta-analysis demonstrated melatonin had a significant benefit in reducing sleep latency.”
Quoted verbatim from Meta-analysis: melatonin for the treatment of primary sleep disorders.. - Study
- meta-analysis
- Population
- Adults and children with primary sleep disorders (insomnia, delayed sleep phase syndrome, REM sleep behaviour disorder) in placebo-controlled trials; primary outcome; fixed-effects pooled estimate, latency measured by polysomnography/actigraphy or by sleep diary depending on trial
Meta-analysis: melatonin for the treatment of primary sleep disorders.2013PMID:23691095Permalink